Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Acute Myeloid Leukaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableApproved For MarketingNCT03070093
What this trial is testing

Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)

Who this might be right for
Acute Myeloid Leukemia (AML)FMS-like Tyrosine Kinase-3 (FLT3) Mutations
Astellas Pharma Global Development, Inc.
Early research (Phase 1)Study completedNCT00060372
What this trial is testing

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more
National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Study completedNCT00045292
What this trial is testing

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04752163
What this trial is testing

DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmRecurrent Acute Lymphoblastic LeukemiaRecurrent Acute Myeloid Leukemia+6 more
M.D. Anderson Cancer Center 17
Early research (Phase 1)Not Yet RecruitingNCT07549464
What this trial is testing

Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT06420063
What this trial is testing

Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML

Who this might be right for
AMLAcute Myeloid LeukemiaAML, Adult Recurrent+1 more
Essen Biotech 85
Testing effectiveness (Phase 2)WithdrawnNCT03207334
What this trial is testing

ICare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-HEM-004)

Who this might be right for
Acute Myeloid Leukemia
University of Florida
Testing effectiveness (Phase 2)Study completedNCT00109993
What this trial is testing

Campath-1H + FK506 and Methylprednisolone for GVHD

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Case Comprehensive Cancer Center 34
Testing effectiveness (Phase 2)Ended earlyNCT00827099
What this trial is testing

Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+2 more
Northside Hospital, Inc. 5
Not applicableEnded earlyNCT00957736
What this trial is testing

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 252
Early research (Phase 1)Looking for participantsNCT05445011
What this trial is testing

Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Testing effectiveness (Phase 2)Study completedNCT03985007
What this trial is testing

CDIAG Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, Relapsed, Adult
The First Affiliated Hospital of Soochow University 40
Early research (Phase 1)Ended earlyNCT06128044
What this trial is testing

CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory
Caribou Biosciences, Inc. 12
Not applicableLooking for participantsNCT06472128
What this trial is testing

Novel Digital Application for Patients With Acute Leukemia

Who this might be right for
Relapsed Adult Acute Myeloid LeukemiaPrimary Refractory Acute Myeloid LeukemiaHigh Risk Acute Myeloid Leukemia
Massachusetts General Hospital 200
Post-approval studies (Phase 4)Study completedNCT03727750
What this trial is testing

Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML

Who this might be right for
ECGPharmacokineticsSafety
Pfizer 51
Not applicableLooking for participantsNCT06845592
What this trial is testing

Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute Leukemia

Who this might be right for
Acute Myeloid Leukaemia (AML)Acute Lymphoblastic Leukemia ALLHigh Risk Leukaemia+1 more
University Of Perugia 51
Early research (Phase 1)Active Not RecruitingNCT00710892
What this trial is testing

CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin's LymphomaMyelodysplastic Syndrome+1 more
Baylor College of Medicine 10
Early research (Phase 1)Active Not RecruitingNCT03912064
What this trial is testing

Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyeloproliferative Neoplasms+2 more
Dana-Farber Cancer Institute 25
Early research (Phase 1)Study completedNCT02891278
What this trial is testing

Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AML

Who this might be right for
Acute Myeloid Leukemia
Columbia University 6
Early research (Phase 1)WithdrawnNCT07566585
What this trial is testing

Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation

Who this might be right for
AML - Acute Myeloid LeukemiaAML With Mutated NPM1AML, Adult Recurrent
BlueSphere Bio, Inc
Next Page